Trials / Sponsors / Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Heart Failure With Preserved Ejection Fraction | Phase 2 | 2024-04-01 |
| Completed | Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction Aft Myocardial Infarction, Acute, Heart Failure, Left Sided | Phase 2 | 2022-07-07 |
| Completed | Clinical Study to Assess Safety, PK and PD Parameters of CDR132L Heart Failure | Phase 1 | 2019-06-21 |